Schmertzler Michael
- SEC CIK
- 0001288952
In the past year, 4 open-market sale filings worth $6.31M and no purchases.
Current role at each company
- PTCT PTC Therapeutics, Inc.Directoras of Sep 18, 2026
- HLNE Hamilton Lane INCDirector, 10% Owneras of Sep 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.31M
- 4 filings
- Net
- −$6.31M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Schmertzler Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTCT PTC Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)5:20 PM ET | Sep 16-17 | 2 days | Schmertzler MichaelDirector | SSale | −20.0K | $67.49 | −$1.35M | −1.5%1.30M after | 4 lots10b5-1 |
| Sep 11, 2026 (view filing)5:20 PM ET | Sep 9-10 | 2 days | Schmertzler MichaelDirector | SSale | −20.0K | $67.59 | −$1.35M | −1.5%1.32M after | 3 lots10b5-1 |
| Aug 28, 2026 (view filing)5:20 PM ET | Aug 26-27 | 2 days | Schmertzler MichaelDirector | SSale | −25.0K | $72.26 | −$1.81M | −1.8%1.34M after | 4 lots10b5-1 |
| Aug 21, 2026 (view filing)5:20 PM ET | Aug 19-20 | 2 days | Schmertzler MichaelDirector | SSale | −25.0K | $72.22 | −$1.81M | −1.8%1.36M after | 5 lots10b5-1 |
| Jan 10, 2024 (view filing) | Jan 8 | 2 days | Schmertzler MichaelDirector | SSale | −1.50K | $27.81 | −$41.7K | −1.3%115.3K after | 10b5-1 |
| Jun 9, 2023 (view filing) | Jun 7 | 2 days | Schmertzler MichaelDirector | SSale | −1.00K | $44.86 | −$44.9K | −0.8%116.8K after | 10b5-1 |